Additionally, advanced diabetes technology, such as continuous subcutaneous insulin infusion (CSII) and continuous glucose monitoring (CGM) devices, helps reduce hemoglobin A1c (HgbA1c) levels as well as hypoglycemia episodes [8–12]. Here, INS is linked to diabetes mellitus.